EP3127917
AÐFERÐ TIL AÐ ÚTBÚA MÓTEFNI MEÐ STJÓRNUN Á SYKURINNIHALDI MÓTEFNIS
:
EP einkaleyfi í gildi á Íslandi:
2.4.2015:
1.9.2021:
15773537.4
:
27.10.2021:
15.11.2021
:
1.4.2035:
1.4.2026:
30.4.2026
:
METHOD FOR PREPARING ANTIBODY THROUGH REGULATION OF SUGAR CONTENT OF ANTIBODY
2.4.2015
1.9.2021
27.10.2021
15.11.2021
1.4.2026
:
PRESTIGE BIOPHARMA PTE. LTD.:
15 Tech Park Crescent, Singapore 638117, SG
:
CHANG, Jae Young:
Daejeon 305-750, KR
:
HWANG, Eun Ho:
Daejeon 305-707, KR
:
KIM, Yong Jin:
Buyeo-gun Chungcheongnam-do 323-814, KR
:
KIM, Won Kyum:
Daejeon 305-358, KR
:
PARK, Sang Kyung:
Daejeon 305-773, KR
:
PARK, Jun Yong:
Incheon 404-190, KR
:
AHN, Kyo Eun:
Seoul 120-100, KR
:
AHN, Yong Ho:
Daejeon 305-340, KR
:
YOON, Ji Yong:
Daejeon 305-745, KR
:
LEE, Jung Woo:
Daejeon 305-805, KR
:
Novagraaf Brevets:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
:
20140039307:
2.4.2014:
KR
:
KR2015003310:
2.4.2015
:
C07K 16/00, C12N 1/38, C12P 21/08
: 8
: 5.4.2022
: 1.4.2023
: Árnason Faktor ehf.
: 9
: 26.3.2023
: 1.4.2024
: Árnason Faktor ehf.
: 10
: 26.3.2024
: 1.4.2025
: Árnason Faktor ehf.
: 11
: 2.4.2025
: 1.4.2026
: Árnason Faktor ehf.